Toolbox TB

Key
Resources
Clinical
Guidelines
Women & Child
Health
Pharmacy &
Technologies
Public
Health
Capacity
Building
COUNTRIES
TOOLBOXES
- Malaria
- NCDs
- Mental Health
- Natural Hazards
- Zika
- TB
- HIV
- Polio
- Rapid Response
- Refugee
- Specific Hazards
- Social Ethics

Middle East and North Africa
West and Central Africa
East and Southern Africa
South–East Asia Region
Western Pacific Region
Eastern Europe and Central Asia
Latin America and the Carribbean
Western and Central Europe
North America

Login
Register
English

TOOLBOX

Suggest new resources

TB
Epidemiology

General

African Region

South-east Asia Region

Latin America

Toolboxes

Filter

Featured

Recommendations

New Publications

Language

English

Spanish

French

Russian

Document type

No document type

Situation Updates

Studies & Reports

Fact sheets

Resource Platforms

Dashboards/Maps

Infographics

Strategic & Response Plan

Countries / Regions

Bangladesh

Latin America and the Carribbean

Paraguay

Namibia

Venezuela

Nigeria

Haiti

Philippines

India

Nepal

Pakistan

Kenya

Cambodia

Indonesia

Myanmar / Burma

Western and Central Europe

Eastern Europe

Timor Leste/ East Timor

Global

Authors & Publishers

World Health Organization (WHO)

World Health Organization WHO

World Health Organization

Pan American Health Organisation PAHO

et al.

Ministry of Health and Family Welfare Government of the People's Republic of Bangladesh

National Tuberculosis Control Programme, Directorate General of Health Services, Ministry of Health and Family Welfare, Bangladesh

PLOS One

Stop TB Partnership

World Health Organisation (WHO)

Alfeus, A.

Amkongo, M.

C. C. Onyedum, I. Alobu, K. N. Ukwaja

C. M. Yuen, H. O. Weyenga, A. A. Kim, et al.

D. P. Chin, C. L. Hanson

ESDC

GBD 2019 Tuberculosis Collaborators

Global TB Programme: H. Getahun, MD, MPH, PhD.

Government of the People’s Republic of Bangladesh, Directorate General of Health Services

Government of the People’s Republic of Bangladesh, Ministry of Health and Family Welfare, Directorate General of Health Services

IDSA

M. J. van der Werf, J. P. Zellweger

Médecines sans Frontièrs MSF

Mitonga, H. K.

National TB Control Programme (NTP), DGHS, MoHFW

National TB Control Programme, Bangladesh

O. Neyrolles (Institut de Pharmacologie et de Biologoie Structurale)

Organisation mondiale de la Santé

Organización Mundial de la Salud OMS

Oxford, et al.

P. Glaziou, C.Sismanidis, P. J. Dodd, et al.

PAHO

Smith, J.P.

The Journal of Infectious Disease

University of Sheffield

WHO

WHO Regional Office for Europe (WHO

WHO ( World Health Organization)

Publication Years

2020-2026

2010-2019

Tuberculosis& Diabetes

World Health Organization (2016) C_WHO

The dual epidemic of TB and Diabetes

External Link

Add to my

Impact of migration on tuberculosis epidemiology and control in the EU/EEA

M. J. van der Werf, J. P. Zellweger ESDC (2016) CC

Euro Surveill. 2016;21(12):pii=30174. DOI: http://dx.doi.org/10.2807/1560-7917.ES.2016.21.12.30174

External Link

Add to my

Comparison of Trends in Tuberculosis Incidence among Adults Living with HIV and Adults without HIV – Kenya, 1998–2012

C. M. Yuen, H. O. Weyenga, A. A. Kim, et al. PLOS One (2014) CC

PLoS ONE 9(6): e99880. doi:10.1371/journal.pone.0099880 Published June 17, 2014

Download

View PDF

Add to my

National Guidelines and Operational Manual for Programmatic Management of Drug Resistant TB (PMDT), 2nd ed.

Government of the People’s Republic of Bangladesh, Directorate General of Health Services (2013) C1

Specific measures are being taken within the National Tuberculosis Control Programme (NTP) to address the MDR TB problem through appropriate management of patients and strategies to prevent the propagation and dissemination of MDR TB.
The term "Programmatic Management of Drug Resistant TB" (PMD ... T) refers to programme based MDR TB diagnosis, management and treatment. This guideline promotes full integration of basic TB control and PMDT activities under the NTP, so that patients with TB are evaluated for drug resistance and are placed on the appropriate treatment regimen and properly managed from the outset of treatment, or as early as possible. The guidelines also integrate the identification and treatment of more severe forms of drug resistance, such as extensively drug resistant TB (XDR TB).
At the end, the guideline introduces new standards for registering, monitoring and reporting outcomes of multidrug resistant TB cases. more